zidovudine has been researched along with thiazoles in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 16 (57.14) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamini, A; Caliò, R; Capozzi, M; Mannella, E; Perno, CF; Rocchi, G; Salanitro, A | 1 |
| Chimirri, A; Grasso, S; Monforte, AM; Monforte, P; Zappalà, M | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Desmyter, J; Herdewijn, P; Pauwels, R; Schols, D; Snoeck, R | 1 |
| Henin, Y; Marechal, V; Montagnier, L; Schwartz, O | 1 |
| Baba, M; De Clercq, E; Desmyter, J; Nakashima, H; Pauwels, R; Schols, D | 1 |
| Allen, LB; Buckheit, RW; Decker, WD; Germany-Decker, J; Hollingshead, MG; McMahon, JB; Ross, LJ; Shannon, WM; Westbrook, L; White, EL | 1 |
| Cinatl, J; Doerr, HW; Gümbel, H; Rabenau, H | 1 |
| Clayette, P; Dereuddre-Bosquet, N; Dormont, D; Fretier, P; Martin, M | 1 |
| Bauer, G; Chen, P; Factor, R; Markham, R; Mitchell, J; Schwartz, DH | 1 |
| Phillips, L | 1 |
| Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Matsumoto, H; Ota, H; Sano, K | 1 |
| Horowitz, D; King, AG | 1 |
| Domagala, J; Gogliotti, R; Gracheck, S; Heldsinger, A; McQuade, T; Sharmeen, L | 1 |
| Vella, S | 1 |
| Chang, HE | 1 |
| Smart, T | 2 |
| Alcorn, K | 1 |
| Gilden, D; Smart, T | 1 |
| MacDougall, DS | 1 |
| Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Kumagai, A; Matsumoto, H; Sano, K | 1 |
| Akbay, A; Aki-Sener, E; Oren, I; Temiz-Arpaci, O; Yalçin, I | 1 |
| Kidd, ME; Modica-Napolitano, JS; Nalbandian, A; Nalbandian, R; Nguyen, CC | 1 |
| D'Cruz, OJ; Tai, HL; Uckun, FM | 1 |
| Benyumov, AO; Downs, S; Dumezb, D; Grigoriants, OO; Tibbles, HE; Uckun, FM; Vassilev, AO; Venkatachalam, TK | 1 |
| Konishi, K; Minematsu, T; Nagasaka, Y; Tabata, K | 1 |
2 trial(s) available for zidovudine and thiazoles
| Article | Year |
|---|---|
Treatment for primary infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Abbott laboratories files New Drug Application for ritonavir.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Double-Blind Method; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
26 other study(ies) available for zidovudine and thiazoles
| Article | Year |
|---|---|
A tetrazolium-based colorimetric assay for quantification of HIV-1-induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony-stimulating factor.
Topics: Colorimetry; Coloring Agents; Cytopathogenic Effect, Viral; Evaluation Studies as Topic; HIV-1; Humans; In Vitro Techniques; Macrophage Colony-Stimulating Factor; Macrophages; Microbial Sensitivity Tests; Monocytes; Tetrazolium Salts; Thiazoles; Virology; Zidovudine | 1992 |
Anti-HIV agents. I: Synthesis and in vitro anti-HIV evaluation of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
Topics: Antiviral Agents; Benzimidazoles; CD4-Positive T-Lymphocytes; Cell Line; Cytopathogenic Effect, Viral; HIV; Humans; Thiazoles; Zalcitabine; Zidovudine | 1991 |
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cell Line, Transformed; Colorimetry; Cytopathogenic Effect, Viral; Dextran Sulfate; Dextrans; Dideoxynucleosides; Drug Evaluation, Preclinical; Heparin; HIV; Humans; Tetrazolium Salts; Thiazoles; Zalcitabine; Zidovudine | 1988 |
A rapid and simple colorimetric test for the study of anti-HIV agents.
Topics: Antiviral Agents; Cell Line; Colorimetry; Cytopathogenic Effect, Viral; Formazans; HIV; Humans; Microbial Sensitivity Tests; Ribavirin; RNA-Directed DNA Polymerase; Tetrazolium Salts; Thiazoles; Virus Replication; Zidovudine | 1988 |
Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds.
Topics: Antiviral Agents; Cell Line; Dideoxynucleosides; HIV-1; HIV-2; Pentosan Sulfuric Polyester; Staining and Labeling; Stavudine; Tetrazolium Salts; Thiazoles; Viral Plaque Assay; Zidovudine | 1989 |
Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
Topics: Antiviral Agents; Base Sequence; Benzimidazoles; Cell Line; Didanosine; DNA, Single-Stranded; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Leukemia Virus, Murine; Molecular Sequence Data; Molecular Structure; Reverse Transcriptase Inhibitors; Thiazoles; Zidovudine | 1993 |
In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.
Topics: Antiviral Agents; Bone Marrow; Bone Marrow Cells; Cell Line; Clone Cells; Colorimetry; Dideoxynucleosides; Drug Resistance; Hematopoietic Stem Cells; HIV-1; HIV-2; Humans; Stem Cells; Tetrazolium Salts; Thiazoles; Zidovudine | 1993 |
Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides.
Topics: Anti-HIV Agents; Dideoxynucleosides; HIV-1; Humans; Microbial Sensitivity Tests; Pyridines; Thiazoles; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1997 |
N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice.
Topics: Acetylcysteine; Animals; Anti-HIV Agents; CD2 Antigens; Cell Division; Cells, Cultured; Coculture Techniques; Down-Regulation; Female; HIV-1; Humans; Intercellular Adhesion Molecule-1; Leukocytes, Mononuclear; Male; Mice; Mice, SCID; Monocytes; Peritoneal Cavity; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Virus Replication; Zidovudine | 1997 |
Antiretroviral drugs: new agents, new combinations line up against HIV.
Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
Topics: Anti-HIV Agents; HIV Protease Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Prodrugs; Reverse Transcriptase Inhibitors; Thiazoles; Zidovudine | 2000 |
Colorimetric determination of inhibition of hematopoietic progenitor cells in soft agar.
Topics: Animals; Antimetabolites; Antimetabolites, Antineoplastic; Antiviral Agents; Colony-Forming Units Assay; Colony-Stimulating Factors; Colorimetry; Coloring Agents; Cytarabine; Cytokines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorouracil; Ganciclovir; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tetrazolium Salts; Thiazoles; Zidovudine | 2000 |
Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374.
Topics: Anti-HIV Agents; Cell Line; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Thiazoles; Virus Replication; Zidovudine | 2001 |
Update on HIV protease inhibitors.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Design; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Phosphorylation; Pyridines; Quinolines; Ritonavir; Saquinavir; Substrate Specificity; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |
Protease inhibitors shine in triple combinations.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Europe out of step with the US.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Costs; Europe; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Ritonavir; Saquinavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
Three days that shook the world.
Topics: Antiviral Agents; Drug Approval; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine; Zidovudine | 1996 |
Ritonavir: first to prolong survival.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Design, synthesis, and biological evaluation of anti-HIV double-drugs. conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers.
Topics: Animals; Anti-HIV Agents; Drug Design; Drug Evaluation, Preclinical; HIV Protease Inhibitors; Humans; Prodrugs; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; Zidovudine | 2001 |
Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives.
Topics: Benzimidazoles; Benzoxazoles; Dideoxynucleotides; HIV Reverse Transcriptase; Indicators and Reagents; Magnetic Resonance Spectroscopy; Pyridines; Reverse Transcriptase Inhibitors; Spectrophotometry, Infrared; Thiazoles; Thymidine; Thymine Nucleotides; Zidovudine | 2003 |
The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
Topics: Adenosine Triphosphate; Carcinoma; Cations; Cell Survival; Colony-Forming Units Assay; Humans; Male; Pyridines; Thiazoles; Thymidine; Tumor Cells, Cultured; Zidovudine | 2003 |
Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07).
Topics: Animals; Antimetabolites, Antineoplastic; Biotransformation; Carboxylic Ester Hydrolases; Cell Division; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Dideoxynucleotides; Drug Resistance, Multiple; Embryo, Nonmammalian; Glutathione; Humans; Leukemia; Nucleosides; Paraoxon; Rhodamine 123; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Thymidine Monophosphate; Tumor Stem Cell Assay; Zebrafish; Zidovudine | 2005 |
Anti-proliferative and anti-leukemic activity of DDE46 (compound WHI-07), a novel bromomethoxylated arylphosphate derivative of zidovudine, and related compounds. Studies using human acute lymphoblastic leukemia cells and the zebrafish model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cell Proliferation; Dideoxynucleotides; Drug Screening Assays, Antitumor; Humans; Jurkat Cells; Leukemia; Magnetic Resonance Spectroscopy; Nephelometry and Turbidimetry; Prodrugs; Tetrazolium Salts; Thiazoles; Thymidine Monophosphate; Tubulin; Zebrafish; Zidovudine | 2005 |
Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment.
Topics: Acetanilides; Adolescent; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aging; Butyrylcholinesterase; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Desipramine; Drug Interactions; Female; Gemfibrozil; Glucuronosyltransferase; Humans; Itraconazole; Lorazepam; Male; Middle Aged; Models, Biological; Renal Insufficiency; Thiazoles; Young Adult; Zidovudine | 2019 |